Design and use of conditional MHC class I ligands
暂无分享,去创建一个
T. Schumacher | B. Rodenko | H. Ovaa | G. Rimmelzwaan | J. Haanen | N. Nieuwkoop | M. Toebes | A. Bins | Raquel Gomez | Willeke van de Kasteele | M. Coccoris | N. J. Nieuwkoop
[1] Chien-Fu Hung,et al. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression , 2005, Nature Medicine.
[2] C. Craddock,et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers , 2005, The Journal of experimental medicine.
[3] J. Stone,et al. HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[4] P. Moss,et al. Cellular immunotherapy for viral infection after HSC transplantation , 2005, Nature Reviews Immunology.
[5] J. Schneck,et al. HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement. , 2004, Clinical immunology.
[6] Mark M Davis,et al. Detection and Characterizationof Cellular Immune Responses Using Peptide–MHC Microarrays , 2003, PLoS biology.
[7] P. Moss,et al. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines , 2003, The Lancet.
[8] J. Falkenburg,et al. Minor histocompatibility antigens in human stem cell transplantation. , 2003, Experimental hematology.
[9] B. Imperiali,et al. Photolytic control of peptide self-assembly. , 2003, Journal of the American Chemical Society.
[10] P. Karplus,et al. Synthesis and characterization of photolabile o-nitrobenzyl derivatives of urea. , 2002, The Journal of organic chemistry.
[11] V. Cerundolo,et al. The use of chimeric A2K(b) tetramers to monitor HLA A2 immune responses in HLA A2 transgenic mice. , 2002, Journal of immunological methods.
[12] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[13] Horst Kessler,et al. Solid-Phase Synthesis of a Nonpeptide RGD Mimetic Library: New Selective αvβ3 Integrin Antagonists , 2001 .
[14] H. Rammensee,et al. SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.
[15] F. Lemonnier,et al. H‐2 class I knockout, HLA‐A2.1‐transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies , 1999, European journal of immunology.
[16] M. Davis,et al. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. , 1999, Journal of immunology.
[17] E. Jaffee,et al. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. Romero,et al. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. , 1998, Journal of immunology.
[19] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[20] S. Riddell,et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.
[21] R. Krance,et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation , 1995, The Lancet.
[22] D. Wiley,et al. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. , 1994, Science.
[23] P. A. Peterson,et al. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.
[24] Don C. Wiley,et al. Atomic structure of a human MHC molecule presenting an influenza virus peptide , 1992, Nature.
[25] D. Wiley,et al. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[26] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[27] Hidde L. Ploegh,et al. Peptide selection by MHC class I molecules , 1991, Nature.
[28] Hidde L. Ploegh,et al. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro , 1990, Cell.
[29] Hidde L. Ploegh,et al. Empty MHC class I molecules come out in the cold , 1990, Nature.
[30] Steven C. Almo,et al. Time-resolved X-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysis , 1990, Nature.